256 filings
Page 5 of 13
8-K
45o39b zmq8susekpx
25 Nov 20
Entry into a Material Definitive Agreement
4:00pm
8-K
bkr7cw qpevzxl9kaf
6 Nov 20
Matinas BioPharma Reports Third Quarter 2020 Financial Results and Operational Highlights
7:55am
8-K
ztzmd7gioo1
4 Nov 20
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
rijfy1iz n3d
19 Oct 20
Regulation FD Disclosure
6:35am
8-K
6e0jpzhka
15 Sep 20
Matinas BioPharma Appoints Industry Veteran Natasha Giordano to Board of Directors
4:45pm
424B5
pqo7gjwoyq p64vomx
10 Aug 20
Prospectus supplement for primary offering
4:05pm
8-K
h10055
10 Aug 20
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights
4:05pm
EFFECT
pk2n5uzg22wtg
10 Aug 20
Notice of effectiveness
12:15am
CORRESP
9pc9w3pv
31 Jul 20
Correspondence with SEC
12:00am
CORRESP
8rcjvxk
27 Jul 20
Correspondence with SEC
12:00am
UPLOAD
htputh
16 Jul 20
Letter from SEC
12:00am
8-K
r3v5k t74yt
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
n2heslcsh6w5ioortaps
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
rklumd6rmcmsz kwsp
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm